Compugen CGEN
NASDAQ CGEN
$2.59 +0.03 (+1.29%)
As of: Sep 4, 2026 · 1:40 PM EDT

Compugen (CGEN) Interest & Investment Income (2009 - 2015)

Compugen (CGEN) posted quarterly Interest & Investment Income of $172000.0 for Q3 2015, up 121.45% year-over-year from $77671.2 in Q3 2014, and up 121.45% on a QoQ basis from -$802000.0 in Q3 2014.

Analysis

Compugen (CGEN) Interest & Investment Income (2009 - 2015) Analysis & Trends

Compugen has reported Interest & Investment Income for 2 years, with the latest figure at $172000.0 in Q3 2015.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int & Inv Inc (Qtr)
1 Vertex Pharmaceuticals 139.31 Bn 131.46 Bn 2.84 Bn 120.60 Mn
2 Regeneron Pharmaceuticals 85.65 Bn 77.66 Bn 3.93 Bn -48.00 Mn
3 Argenx Se 63.46 Bn 58.27 Bn 1.37 Bn 48.00 Mn
4 Moderna 57.94 Bn 52.80 Bn 52.00 Mn 67.00 Mn
5 Revolution Medicines 44.05 Bn 44.05 Bn - 35.58 Mn
6 BeOne Medicines 39.96 Bn 34.86 Bn 1.53 Bn 27.90 Mn
7 Alnylam Pharmaceuticals 35.16 Bn 31.85 Bn 992.69 Mn 28.14 Mn
8 Royalty Pharma 28.44 Bn 27.60 Bn - 5.13 Mn
9 Insmed 27.32 Bn 26.16 Bn 358.27 Mn 10.98 Mn
10 Compugen 241.97 Mn 156.35 Mn -92,000.00 -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2015 172,000.00
Dec 31, 2014 88,000.00
Sep 30, 2014 -802,000.00
Jun 30, 2014 1.06 Mn
Jun 30, 2013 1.68 Mn
Jun 30, 2012 2.33 Mn
Jun 30, 2011 1.22 Mn
Dec 31, 2010 -111,000.00
Sep 30, 2010 312,000.00
Jun 30, 2010 41,000.00
Sep 30, 2009 181,000.00
Jun 30, 2009 279,000.00